JulaInrigMDMHS, FASN

PubMed

• 1 citations
  Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy.
  Trachtman, H., Komers, R., Inrig, J.> ;Expert Review of Clinical Immunology. 2024 Feb 26
• 7 citations
  Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
  Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses A Diva, Jürgen Floege, Loreto Gesualdo, Jula K Inrig, Don...> ;Lancet. 2023 Dec 2
• 1 citations
  Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial.
  Howard Trachtman, Ulysses Diva, Edward Murphy, Kaijun Wang, Jula Inrig, Radko Komers> ;Kidney International Reports. 2023 Oct 1
• Status of current trials and potential future trials with sparsentan.
  Howard Trachtman, Radko Komers, Jula Inrig> ;Expert Opinion on Emerging Drugs. 2023 Dec 1
• 11 citations
  IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study.
  Jonathan Barratt, Brad Rovin, Muh Geot Wong, Charles E Alpers, Stewart Bieler, Ping He, Jula Inrig, Radko Komers, Hiddo J L Heerspink, Alex Mercer, Irene L Noronha, Ja...> ;Kidney International Reports. 2023 May 1
• 35 citations
  Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
  Hiddo J L Heerspink, Jai Radhakrishnan, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Ulysses Diva, Jula Inrig, Radko Komers, Alex Mercer, Irene L Noronha, Miche...> ;Lancet. 2023 May 13
• 12 citations
  Dietary protein intake, kidney function, and survival in a nationally representative cohort
  Yoko Narasaki, Yusuke Okuda, Linda W. Moore, Amy S. You, Ekamol Tantisattamo, Jula K. Inrig, Tsuyoshi Miyagi, Tracy Nakata, Csaba P. Kovesdy, Danh V. Nguyen, Kamyar Ka...> ;The American Journal of Clinical Nutrition. 2021 Jul 1
• 32 citations
  Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis.
  Radko Komers, Ulysses Diva, Jula K. Inrig, Andrea Loewen, Howard Trachtman, William E. Rote> ;Kidney International Reports. 2020 Jan 8
• 4 citations
  Beware Intradialytic Hypotension: How Low Is Too Low?
  Jula K. Inrig> ;Clinical Journal of the American Society of Nephrology. 2018 Oct 8
• 8 citations
  There's no place like home: 35-year patient survival on home hemodialysis.
  Jerry Z. Yu, Connie M. Rhee, Antoney Ferrey, Alex Li, Anna Jin, Yongen Chang, Uttam Reddy, Wei Ling Lau, Jason A. Chou, Jula K. Inrig, Kamyar Kalantar-Zadeh> ;Seminars in Dialysis. 2018 May 1
• 94 citations
  Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients.
  Jason A. Chou, Elani Streja, Danh V. Nguyen, Connie M. Rhee, Yoshitsugu Obi, Jula K. Inrig, Alpesh Amin, Csaba P. Kovesdy, John J. Sim, Kamyar Kalantar-Zadeh> ;Nephrology, Dialysis, Transplantation. 2018 Jan 1
• 16 citations
  Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.
  Peter N. Van Buren, Jula K. Inrig> ;Seminars in Dialysis. 2017 Jun 30
• 20 citations
  Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension.
  Peter N. Van Buren, Yunyun Zhou, Javier A. Neyra, Guanghua Xiao, Wanpen Vongpatanasin, Jula K. Inrig, Robert D. Toto> ;Kidney & Blood Pressure Research. 2016 Nov 11
• 27 citations
  Overcoming Barriers in Kidney Health—Forging a Platform for Innovation
  Peter Linde, Patrick Archdeacon, Matthew D. Breyer, Tod Ibrahim, Jula K. Inrig, Reshma Kewalramani, Celeste Castillo Lee, Carolyn Y. Neuland, Prabir Roy-Chaudhury, Jam...> ;Journal of the American Society of Nephrology. 2016 Jul 1
• 10 citations
  Comparison of Ambulatory Blood Pressure Patterns in Patients With Intradialytic Hypertension and Hemodialysis Controls.
  Catherine Hompesch, Tsung Wei Ma, Javier A. Neyra, Lindsay Ripley, Guanghua Xiao, Jula K. Inrig, Robert D. Toto, Peter N. Van Buren> ;Kidney & Blood Pressure Research. 2016 Apr 22
• 23 citations
  Mechanisms and Treatment of Intradialytic Hypertension.
  Peter N. Van Buren, Jula K. Inrig> ;Blood Purification. 2016 Jan 15
• 601 citations
  KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
  Michael Rocco, John T. Daugirdas, Thomas A. Depner, Jula K. Inrig, Rajnish Mehrotra, Michael V. Rocco, Rita S. Suri, Daniel E. Weiner, Nancy Greer, Areef Ishani, Roder...> ;American Journal of Kidney Diseases. 2015 Nov 1
• 38 citations
  Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study.
  Jula K. Inrig, Christopher Molina, Kristin M. D’Silva, Catherine Kim, Peter N. Van Buren, Jason D. Allen, Robert D. Toto> ;American Journal of Kidney Diseases. 2015 Mar 1
• 103 citations
  The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov
  Jula K. Inrig, Robert M. Califf, Asba Tasneem, Radha K. Vegunta, Christopher Molina, John W. Stanifer, Karen Chiswell, Uptal D. Patel> ;American Journal of Kidney Diseases. 2014 May 1
• 4 citations
  Peri-dialytic hypertension and hypotension: another U-shaped BP-outcome association
  Jula K. Inrig> ;Kidney International. 2013 Oct 1
• 71 citations
  Association of Intradialytic Blood Pressure Variability With Increased All-Cause and Cardiovascular Mortality in Patients Treated With Long-term Hemodialysis
  Jennifer E. Flythe, Jula K. Inrig, Tariq Shafi, Tara I. Chang, Kathryn Cape, Kumar Dinesh, Shrikanth Kunaparaju, Steven M. Brunelli> ;American Journal of Kidney Diseases. 2013 Jun 1
• 119 citations
  Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease
  Peter A. McCullough, Huiman X. Barnhart, Jula K. Inrig, Donal N. Reddan, Shelly Sapp, Uptal D. Patel, Lynda A. Szczech, Robert M. Califf, Ajay K. Singh> ;American Journal of Nephrology. 2013 Jan 1
• 33 citations
  The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up
  Peter N. Van Buren, Catherine Kim, Robert D. Toto, Jula K. Inrig> ;The International Journal of Artificial Organs. 2012 Sep 6
• 26 citations
  Effect of Hemoglobin Target on Progression of Kidney Disease: A Secondary Analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) Trial
  Jula K. Inrig, Huiman X. Barnhart, Donal N. Reddan, Uptal D. Patel, Shelly Sapp, Robert M. Califf, Lynda A. Szczech, Ajay K. Singh> ;American Journal of Kidney Diseases. 2012 Sep 1
• 29 citations
  Comparing Mandated Health Care Reforms: The Affordable Care Act, Accountable Care Organizations, and the Medicare ESRD Program
  Suzanne Watnick, Daniel E. Weiner, Rachel Shaffer, Jula K. Inrig, Sharon M. Moe, Rajnish Mehrotra> ;Clinical Journal of the American Society of Nephrology. 2012 Sep 1
• Join now to see all

Journal Articles

• Intradialytic blood pressure variability is associated with increased all-cause and cardiovascular mortality  
  Flythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, Kunaparaju S, Brunelli SM, Am J Kidney Dis, 3/6/2013
• Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.  
  McCullough PA, Barnhart HX, Inrig JK, Reddan D, Sapp S, Califf RM, Patel UD, Singh AK, Szczech LA, Am J Nephrol, 1/1/2013
• Practice Pointers: Hypertension and blood pressure goals in the dialysis unit.  
  Inrig JK and Griffiths K, ASN Kidney News, 1/1/2013
• The Prevalance Rate of Persistent Intradialytic Hypertension in a Hemodialysis Population With Extended Follow-Up  
  Van Buren P, Kim C, Toto RD, Inrig JK, International Journal of Artificial Organs, 12/1/2012
• Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.  
  Inrig JK, Sapp S, Barnhart H, Patel UD, Reddan D, Singh AJ, Califf RM, Szczech LA, Nephrology Dialysis Transplantation, 9/1/2012
• The Affordable Care Act, Accountable Care Organizations, and the Medicare ESRD Program.  
  Watnick S, Weiner DE, Shaffer R, Inrig JK, Moe S, Mehrotra R on behalf of the Dialysis Advisory Group of the ASN, cJASN, 9/1/2012
• New Perspectives on Blood Pressure Variability in Hemodialysis Patients. Editorial  
  Van Buren P, Shastri SS, Inrig JK, AJKD, 1/1/2012
• Effect of Hemoglobin Target on Progression of Kidney Disease: A Secondary Analysis of the CHOIR Trial.  
  Inrig JK, Barnhart H, Reddan D, Patel UD, Sapp S, Califf RM, Singh AJ, Szczech LA, Am J Kidney Dis, 1/1/2012
• Considerations in the optimal preparation of patients for dialysis.  
  Saggi SJ, Allon M, Bernardini J, Kalantar-Zadeh K, Shaffer R, Mehrotra R; Dialysis Advisory Group of the American Society of Nephrology, Nat Rev Nephrol, 1/1/2012
• Reimbursement of dialysis: a comparison of seven countries.  
  Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N, Lonnemann G, Magner P, Mendelssohn D, Saggi SJ, Shaffer RN, Moe SM, Van Biesen W, van der Sand..., J Am Soc Nephrol, 1/1/2012
• How to overcome barriers and establish a successful home HD program.  
  Young BA, Chan C, Blagg C, Lockridge R, Golper T, Finkelstein F, Shaffer R, Mehrotra R, ASN Dialysis Advisory Group, cJASN, 1/1/2012
• Effect of Cinacalcet on cardiovascular disease in patients undergoing dialysis.  
  Evolve Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ..., NEJM, 1/1/2012
• Differential outcomes between dialysis modalities: purely a reflection of selection bias? Editorial on hemodialysis vascular access modified the association between d...  
  Inrig JK and Toto RD, JASN, 1/1/2011
• ASN End-Stage Renal Disease Task Force: Perspective on Prospective Payments for Renal Dialysis Facilities.  
  Hostetter T, Sedor JR, Watnick S, Patel UD, Cheung A, Harmon WE, Himmelfarb J, Inrig JK, Mehrotra R, Robinson E, Smedberg PC, Shaffer RN for the American Society of Ne..., J Am Soc Nephrol, 1/1/2010
• Response to "Malignant" Intradialytic Hypertension: A Severe Form of Intradialytic Hypertension.  
  Inrig JK, Am J Kidney Disease, 1/1/2010
• "Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure."  
  Steven Fishbane and Nobuyuki Miyawaki, Kidney International, 1/1/2010
• "Peridialytic, Intradialytic, and Interdialytic Blood Pressure Measurement in Hemodialysis Patients."  
  Arjun Sinha and Rajiv Agarwal, American Journal Kidney Diseases, 1/1/2009
• "Falls in systolic blood pressure during hemodialysis relate to good short-term outcome." (Research Highlights)  
  Inrig JK, Nature Clinical Practice Journal of Nephrology, 5/1/2007
• Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia  
  Inrig JK, Reed S, Szczech LA, Engemann J, Friedman JY, Corey RC, Schulman K, Reller LB, Fowler VG, Clin J Am Soc Nephrol, 1/1/2006
• Join now to see all

Books/Book Chapters

• UpToDate 
  Chapter: Leptin and end-stage renal disease. 
  Inrig JK and Szczech LAEditors: BD Rose.UpToDate, Waltham, MA2013
• Global HIV/AIDS Medicine 
  Chapter: Renal Complications of HIV Infections. 
  Page 299 - 307Inrig JK, Szczech LA, Gerntholtz TE, Klotman PEEditors: PA Volderbing, MA Sande, J Lange, WC Greene.Elsevier Publishers, Philadelphia, PA2008

Abstracts/Posters

• Dialysate Sodium Promotes Endothelial Cell Dysfunction in Patients with Intradialytic Hypertension.
  Kim C, Van Buren P, Klimas N, Inrig JK, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
• Systematic Analysis of Nephrology Studies in ClinicalTrials.gov.
  Inrig JK, Califf RM, Tasneem A, Chiswell K, Patel UD, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
• Desing and Rationale for a randomized, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of nalfurafine (MT_9938) for treatment of uremic ...
  Yosipovich G, Inrig J, Mayo Marlyn, Block G, Takei K, Lieberman B, Palumbo JM, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
• Hourly ambulatory BP Patterns in Patients with Intradialytic Hypertension.
  Van Buren P, Kim C, Srivastasa A, Toto RD, Inrig JK, American Society of Nephrology, Philadelphia, PA, 11/1/2011
• Mean Hemodialysis-Unit Systolic BP is Similar in Patients With and Without Frequent Intradialytic Hypertension.
  Van Buren PN, Kim C, Toto R, Inrig JK, American Society of Hypertension Annual Meeting, New York, NY, 5/1/2011
• Blood Pressure Variability is Not Greater Among Patients with Intradialytic Hypertension.
  Kim C, Van Buren P, Toto RD, Inrig JK, American Society of Hypertension Annual Meeting, New York, NY, 5/1/2011
• Higher ambulatory blood pressure in not associated with endothelial cell dysfunction among maintenance hemodialysis patients.
  Inrig JK, Van Buren P, Kim C, Toto RD, World Congress of Nephrology Annual Meeting, 4/9/2011
• Prevalence of Intradialytic Hypertension over 6 months in a HD Cohort.
  Van Buren PN, Kim C, Toto R, Inrig JK, National Kidney Foundation Spring Clinical Meeting, 4/1/2011
• Intradialytic Hypertension Is Associated With Endothelial Cell Dysfunction: Results of the Mechanism and Treatment of Intradialytic Hypertension (MATCH) Study
  Inrig JK, Van Buren P, Kim C, Toto RD, American Society of Nephrology Annual Meeting, 11/19/2010
• Association between high-dose ESA, inflammatory biomarkers, and soluble erythropoietin receptors.
  Inrig JK, Patel UD, Bryskin S, Szczech LA, American Society of Nephrology Annual Meeting, 10/9/2009
• Veterans More Likely to Dtart Hemodialysis with an Arteriovenous Fistula.
  Parikh, DS, Kipp AP, Inrig JK, Krisher LA, Szczech LA, McClellan U, Patel UD, American Society of Nephrology Annual Meeting, 11/8/2008
• Lowering Pulse Pressure during Hemodialysis and Improved 6-month Outcomes.
  Inrig JK, Patel UD, Toto R, Reddan D, Szczech LA, American Society of Nephrology Annual Meeting, 11/8/2008
• Dietary Habits among Adults with Chronic Kidney Disease: Accordance with the Dash Diet.
  Hester W, Inrig JK, Szczech LA, Svetkey LP, Patel UP, American Society of Nephrology Annual Meeting, 11/8/2008
• Lack of Association between Chronic Kidney Disease and Wide Pulse Pressure among Adults in the United States.
  Hester W, Inrig JK, Szczech LA, Svetkey LP, Patel UP, American Heart Association High Blood Pressure Conference 62nd Annual Meeting, 9/1/2008
• Inpatient costs and clinical outcomes of S. aureus bloodstream and non-bloodstream infection in patients with end-stage renal disease: Findings from a multi-center trial.
  Li Y, Friedman JY, O'Neal BF, MJ H, Griffiths RI, Stryjewski ME, Schulman KA, Inrig JK, Fowler VF, Reed SD, International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting, 5/1/2008
• Trends in coronary artery bypass graft surgery among ESRD patients.
  Parikh DS, Swaminathan M, Archer LE, Inrig JK, Szczech LA, Shaw AD, Patel UD, AJKD, National Kidney Foundation Annual Meeting, 4/1/2008
• The Paradox Between Hypertension Awareness, Treatment and Control Among Adults with Chronic Kidney Disease in the United States.
  Patel UD, Hester WE, Inrig JK, Peralta CA, Shlipak MG, Szczech LA, Svetkey LP, Hypertension, 1/1/2008
• The association between epoetin-alfa dose and outcomes in CHOIR: Correction of Hemoglobin and Outcomes in Renal Insufficiency.
  Szczech LA, Barnhart H, Inrig JK, Reddan D, Sapp S, Califf RM, Patel UD, Singh AJ, American Society of Nephrology Annual Meeting, 11/4/2007
• The Risk of Progression of Chronic Kidney Disease (CKD) and Mortality Associated with Percutaneous Cardiac Procedures among Patients with Acute Coronary Syndrome.
  Inrig JK, Briley LP, Patel UD, She L, Gillespie B, Easton JD, Topol E, Szczech LA, American Society Nephrology Annual Meeting, 11/1/2006
• Clinical Outcomes in Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia treated with Vancomycin or First Generation Cephalos...
  Stryjewski ME, Benjamin DK, Szczech LA, Inrig JK, Engemann JJ, Chu VH, Reller B, Corey RG, Fowler VF, Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 12/1/2005
• Mortality Differences by Dialysis Modality among ESRD Patients Awaiting Renal Transplant.
  Inrig JK, Yang Q, Briley LP, Lehrich R, Szczech LA, American Society Nephrology Annual Meeting, 11/1/2005
• Case Report on Propylthiouracil Induced P-Anca Positive Vasculitis and Review of the Literature.
  Inrig JK, Skoretz LE, Firek AF, Annual Alumni Postgraduate Convention, 3/1/2000
• Isolation, Subfractionation, and Enzymatic Analysis of Avocado Mitochondria.
  Kern, Jula L, Annual Graduate Conference, California State University of Sacramento, Biochemistry Department, 5/1/1996
• Join now to see all

Lectures

• Topic: Blood Pressure, Salt and Water in Hemodialysis Patients 
  10/10/2013
• The Effect Of Dialysate Sodium On Intradialytic Hypertension. 
  San Francisco, CA - 4/28/2013
• Strategies to Optimize Blood Pressure Management in Dialysis 
  4/19/2013
• Mechanisms and Treatment Strategies of Intradialytic Blood Pressure Changes 
  4/5/2013
• Bundled Payments: Increased Transfusions, Changing Practice Patterns, No Quality Measures 
  11/2/2012
• Ameliorating intradialytic hypotension, intra- and inter-dialytic hypertension by altering hemodialysis prescription? 
  10/31/2012
• Additional Panel Discussion: Salt and water removal with hemodialysis 
  10/31/2012
• The Effect of Dialysate Sodium on Endothelial Cell Function and Blood Pressure 
  10/31/2012
• Hemodialysis: Blood Pressure, Volume Control, and Preventing Cardiovascular Comorbidities 
  2013 American Society of Nephrology Board Review Course, August 15, 2013 - 8/30/2012
• Hemodialysis: Sleep Disturbances, restless legs, and amyloid 
  2013 American Society of Nephrology Board Review Course, August 15, 2013 - 8/30/2012
• Chronic Kidney Disease and Management including 
  8/12/2012
• Chronic Kidney Disease Management 
  8/2/2012
• Hematuria and Proteinuria 
  7/30/2012
• Effects of Doxercalciferol on EC Function 
  6/21/2012
• Blood Pressure Regulation and Endothelial Cell Function in Kidney Disease 
  3/23/2012
• Management of Chronic Kidney Disease 
  3/21/2012
• Cardiovascular Complications of Hypertension during Hemodialysis 
  3/8/2012
• Microhematuria and Trace Proteinuria 
  3/1/2012
• Dry Weight Management/Ultrafiltration/Sodium Control 
  2/25/2012
• Management of Hypertension in Dialysis 
  12/5/2011
• Abnormal Urinalysis: Hematuria and Trace Proteinuria 
  9/1/2011
• Microscopic Hematuria and Proteinuria 
  8/15/2011
• Carvedilol for the treatment of intradialytic hypertension: the mechanisms and treatment of intradialytic hypertension (MATCH) study. 
  5/22/2011
• Intradialytic Hypertension and Cardiovascular Complications 
  5/6/2011
• Changing the Approach to Dyslipidemia Management in CKD 
  4/27/2011
• Join now to see all

Other

• Blood Pressure with Epo 
  Inrig JK, Renal and Urology News, Jody A. Charnow
  11/1/2012
• "Dialysis Data Shines Light on Clinic Disparities Detailed information on North Texas dialysis clinic death rates." 
  Inrig JK, NBC Interview with Ken Kalthoff
  http://www.nbcdfw.com/news/health/Dialysis-Data-Shines-Light-on-Clinic-Disparities-147838245.html
  4/17/2012
• Hot issues to watch for in 2011 
  Inrig JK, Saggi S, Weiner D, Shaffer R, Mehrotra on behalf of the ASN Dialysis Advisory Group. Bundled Payments, ASN Kidney News
  1/1/2011
• "Data Suggest a Mechanism for ESA Resistance" 
  Inrig JK, Renal and Urology News, Jody A. Charnow
  11/1/2009
• Inpatient costs and clinical outcomes of S. aureus bloodstream and non-bloodstream infection in patients with end-stage renal disease: Findings from a multi-center trial. 
  Li Y, Friedman JY, O'Neal BF, MJ H, Griffiths RI, Stryjewski ME, Schulman KA, Inrig JK, Fowler VF, Reed SD, Value in Health
  1/1/2008
• "Weight Gain affects SBP" 
  Inrig JK, Renal and Urology News, Jody A. Charnow
  8/1/2007
• "PD's Higher Mortality Rate Confirmed: Study of transplant eligible patients is the largest to compare peritoneal dialysis and hemodialysis. Difference in death risk f... 
  Inrig JK, Renal and Urology News, Jody A. Charnow
  1/1/2006
• Staphylococcus aureus Infections in Hemodialysis Patients. 
  Inrig JK and Fowler VG, Ochsner Clinic Foundation Reports
  4/1/2005
• News Related to Hematide 
  Inrig JK, Bloomberg
  http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a1meTJTyj3g8
• Intradialytic Hypertension and Interdialysic Ambulatory Blood Pressure 
  Inrig JK
  http://www.hemodialysis.com/author_interview_dr_vanburen_intradialytic_hypertension_and_interdialysi
• Statins new data provide additional support for use in CKD (Guest Commentary) 
  Inrig JK, Nephrology Times, Janelle Weaver
• Leptin and end-stage renal disease 
  Inrig JK, Szczech L
  http://www.uptodate.com/contents/leptin-and-end-stage-renal-disease
  UpToDate, Wolters Kluwer Health - 2012-02-29
• Join now to see all